Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis.
暂无分享,去创建一个
[1] P. Libby. Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[2] M. Febbraio,et al. Dietary Cholesterol Plays a Role in CD36-Mediated Atherogenesis in LDLR-Knockout Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[3] R. Silverstein,et al. CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior , 2009, Science Signaling.
[4] Hyunsuk Shim,et al. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. , 2009, Cancer research.
[5] K. Moore,et al. Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[6] R. Silverstein,et al. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. , 2008, The Journal of clinical investigation.
[7] R. Silverstein,et al. A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein , 2008, Circulation research.
[8] K. McCrae,et al. Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. , 2008, The Journal of clinical investigation.
[9] M. Greenberg,et al. The Lipid Whisker Model of the Structure of Oxidized Cell Membranes* , 2008, Journal of Biological Chemistry.
[10] S. Hazen,et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.
[11] T. Hartung,et al. Membrane Sorting of Toll-like Receptor (TLR)-2/6 and TLR2/1 Heterodimers at the Cell Surface Determines Heterotypic Associations with CD36 and Intracellular Targeting* , 2006, Journal of Biological Chemistry.
[12] J. Koenigsknecht-Talboo,et al. Fibrillar β-Amyloid-stimulated Intracellular Signaling Cascades Require Vav for Induction of Respiratory Burst and Phagocytosis in Monocytes and Microglia* , 2006, Journal of Biological Chemistry.
[13] S. Hazen,et al. Light-induced Oxidation of Photoreceptor Outer Segment Phospholipids Generates Ligands for CD36-mediated Phagocytosis by Retinal Pigment Epithelium , 2006, Journal of Biological Chemistry.
[14] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[15] K. Moore,et al. Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain , 2005, The Journal of cell biology.
[16] Thomas Hartung,et al. CD36 is a sensor of diacylglycerides , 2005, Nature.
[17] G. Sumara,et al. Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis , 2004, Science.
[18] R. Hebbel,et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.
[19] J. Chou,et al. Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.
[20] S. Hazen,et al. A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* , 2002, Journal of Biological Chemistry.
[21] R. Silverstein,et al. Differential Roles of CD36 and αvβ5 Integrin in Photoreceptor Phagocytosis by the Retinal Pigment Epithelium , 2001, The Journal of experimental medicine.
[22] R. Silverstein,et al. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.
[23] R. Westrick,et al. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[24] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[25] R. Silverstein,et al. A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.
[26] G. Grau,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.
[27] Loise M. Francisco,et al. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.
[28] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[29] David W. Dawson,et al. CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.
[30] D. Lublin,et al. CD36 Is Palmitoylated on Both N- and C-terminal Cytoplasmic Tails* , 1996, The Journal of Biological Chemistry.
[31] M. Lagueux,et al. Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. , 1996, Immunity.
[32] S. Ryeom,et al. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. , 1996, Journal of cell science.
[33] P. Grimaldi,et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.
[34] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[35] J Savill,et al. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. , 1992, The Journal of clinical investigation.
[36] D. Steinberg,et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Barnwell,et al. Isolation of the thrombospondin membrane receptor. , 1987, The Journal of clinical investigation.
[38] V. D’Agati,et al. Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium. , 1984, Journal of immunology.
[39] S. Pfueller,et al. Isolation of the membrane glycoproteins of human blood platelets by lectin affinity chromatography. , 1977, Biochimica et biophysica acta.
[40] K. Matsumoto,et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[41] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[42] J. Dopazo,et al. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. , 1995, Genomics.